Aytu Bioscience announces first sales for male infertility system

Aytu Bioscience announces first sales for male infertility system

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on commercializing treatments for urological conditions, today announced the first... Read More

Tuesday February 9, 2016 0 comments Tags: Aytu BioScience, Josh Disbrow, Englewood, MiOXSYS, male infertility

IN Sponsors

Content Garden ad

Browse

Sundyne enhances LMV 803Lr Pump with improved capabilities to minimize install, maintenance costs
Sundyne enhances LMV 803Lr Pump with improved capabilities to minimize install, maintenance costs
Paragon 28 receives FDA approval for APEX 3D total ankle replacement system
Paragon 28 receives FDA approval for APEX 3D total ankle replacement system
Guidehouse: Global smart home device market to see 18% growth through 2029
Guidehouse: Global smart home device market to see 18% growth through 2029
$100M fund launched to fight pandemic by supporting tech startups
$100M fund launched to fight pandemic by supporting tech startups
Trust is a two-way street. Why brake when a shared purpose guides you?
Trust is a two-way street. Why brake when a shared purpose guides you?

Entrepreneurial by Nature


Colorado Entreprenerial by Nature
Copyright InnovatioNews LLC 2015. All Rights Reserved.